takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
Tadataka Yamada M.D., Ph.D.
Former Chief Medical & Scientific Officer, Director and Executive Vice President of Takeda Pharmaceuticals International, Inc, Takeda Pharmaceutical Company Limited
|Age||Total Calculated Compensation||This person is connected to 110 board members in 6 different organizations across 11 different industries.|
See Board Relationships
As of Fiscal Year 2015
Dr. Tadataka Yamada, also known as Tachi, Ph.D., M.D., serves as a Venture Partner to Life Sciences team and Senior Advisor to Growth Buyout team at Frazier Healthcare, since July 6, 2015. He focuses on creating companies as well as providing strategic guidance to existing portfolio companies and provides advice on opportunities in pharmaceutical services and spin-outs from large healthcare companies. He has rejoined the firm. He has been a Corporate Officer and Head ...
1-1, Doshomachi 4-chomePhone: 81 6 6204 2111
Osaka, -- 540-8645
Fax: 81 6 6204 2880
Board Members Memberships*
Executive Vice President, Medical & Scientific Advisor to the Chief Executive Officer and Director
Director, Member of Compensation Committee and Member of Nominating/Corporate Governance Committee
New York University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|